These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26861241)
21. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547 [TBL] [Abstract][Full Text] [Related]
22. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151 [TBL] [Abstract][Full Text] [Related]
23. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Cummings CJ; Orr HT; Zoghbi HY Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309 [TBL] [Abstract][Full Text] [Related]
24. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects. Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793 [TBL] [Abstract][Full Text] [Related]
25. Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Rüb U; Schöls L; Paulson H; Auburger G; Kermer P; Jen JC; Seidel K; Korf HW; Deller T Prog Neurobiol; 2013 May; 104():38-66. PubMed ID: 23438480 [TBL] [Abstract][Full Text] [Related]
27. Protein Environment: A Crucial Triggering Factor in Josephin Domain Aggregation: The Role of 2,2,2-Trifluoroethanol. Visentin C; Navarro S; Grasso G; Regonesi ME; Deriu MA; Tortora P; Ventura S Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042316 [TBL] [Abstract][Full Text] [Related]
28. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3. Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650 [TBL] [Abstract][Full Text] [Related]
29. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Scheel H; Tomiuk S; Hofmann K Hum Mol Genet; 2003 Nov; 12(21):2845-52. PubMed ID: 12944423 [TBL] [Abstract][Full Text] [Related]
30. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells. Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820 [TBL] [Abstract][Full Text] [Related]
31. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Chow MK; Mackay JP; Whisstock JC; Scanlon MJ; Bottomley SP Biochem Biophys Res Commun; 2004 Sep; 322(2):387-94. PubMed ID: 15325242 [TBL] [Abstract][Full Text] [Related]
33. Insights into the evolution and domain structure of Ataxin-2 proteins across eukaryotes. Jiménez-López D; Guzmán P BMC Res Notes; 2014 Jul; 7():453. PubMed ID: 25027299 [TBL] [Abstract][Full Text] [Related]
34. Polyglutamine tracts regulate autophagy. Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC Autophagy; 2017 Sep; 13(9):1613-1614. PubMed ID: 28722507 [TBL] [Abstract][Full Text] [Related]
35. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse. Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954 [TBL] [Abstract][Full Text] [Related]
36. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation. Chou AH; Chen YL; Hu SH; Chang YM; Wang HL Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423 [TBL] [Abstract][Full Text] [Related]
37. Comparative genetics of the poly-Q tract of ataxin-1 and its binding protein PQBP-1. Kurosaki T; Gojobori J; Ueda S Biochem Genet; 2012 Apr; 50(3-4):309-17. PubMed ID: 21964520 [TBL] [Abstract][Full Text] [Related]
38. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra. Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908 [TBL] [Abstract][Full Text] [Related]
39. Polyglutamine expansion of ataxin-3 alters its degree of ubiquitination and phosphorylation at specific sites. Kristensen LV; Oppermann FS; Rauen MJ; Hartmann-Petersen R; Thirstrup K Neurochem Int; 2017 May; 105():42-50. PubMed ID: 28065793 [TBL] [Abstract][Full Text] [Related]
40. Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate. Fittschen M; Lastres-Becker I; Halbach MV; Damrath E; Gispert S; Azizov M; Walter M; Müller S; Auburger G Neurogenetics; 2015 Jul; 16(3):181-92. PubMed ID: 25721894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]